Thalassaemia Pipeline Highlights – 2017 Update
Topics: Blood Diseases, Manufacturing, Packaging & Detailing, Drug Discovery
|
Blood Disorders Pipeline Database – 2017 Update
Topics: Blood Diseases
|
Global Sickle Cell Anemia Market and Competitive Landscape – 2017
Topics: Blood Diseases
Regions: Global
|
Global Hemophilia Market and Competitive Landscape – 2017
Topics: Blood Diseases
Regions: Global
|
Global Anemia Partnering 2010 to 2017
Topics: Blood Diseases
Regions: Global
|
Global Hemophilia Partnering 2010 to 2017
Topics: Blood Diseases
Regions: Global
|
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2017
Topics: Blood Diseases, Drug Discovery
|
Europe Hemophilia Market and Competitive Landscape – 2017
Topics: Blood Diseases
Regions: Europe
|
Hemophilia Pipeline Highlights – 2017 Update
Topics: Blood Diseases, Manufacturing, Packaging & Detailing, Drug Discovery
|
Thrombocytopenia Pipeline Highlights – 2017 Update
Topics: Blood Diseases, Manufacturing, Packaging & Detailing, Drug Discovery
|
Europe Von Willebrand Disease Market and Competitive Landscape – 2017
Topics: Blood Diseases
Regions: Europe
|
Chemotherapy Induced Anemia - Pipeline Review, H2 2017
Topics: Blood Diseases, Drug Discovery
|
Europe Sickle Cell Anemia Market and Competitive Landscape – 2017
Topics: Blood Diseases
Regions: Europe
|
Europe Thalassemia Market and Competitive Landscape – 2017
Topics: Blood Diseases
Regions: Europe
|
Global Sickle Cell Market- Industry Analysis & Outlook (2020-2030)
Topics: Blood Diseases, Drug Discovery
Regions: Global
|
Hematology Drugs Market Global Briefing 2017Including: Blood Products, Anemia And Other Blood Disorder Drugs.Covering: Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company, Limited, Biogen Inc., Pfizer Inc.
Topics: Blood Diseases, Pharmaceuticals Company Reports, Oncology/Hematology
Regions: Global
|
Global Hemophilia Treatment Drugs Market Research Report 2017
Topics: Blood Diseases
Regions: Global
|
Market Access Impact (US) [Haemophilia B]
Topics: Blood Diseases
Regions: United States
|
Chemotherapy Induced Anemia - Pipeline Insight, 2017
Topics: Blood Diseases, Drug Discovery
|
Aplastic Anemia - Market Insights, Epidemiology and Market Forecast – 2025
Topics: Blood Diseases
|
Von Willebrand Disease - Market Insights, Epidemiology and Market Forecast – 2025
Topics: Blood Diseases
|
Aplastic Anemia - Epidemiology Insights to 2025
Topics: Blood Diseases
|
Blood Coagulation Factor Activators -Pipeline Insights, 2017
Topics: Blood Diseases
|
Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need
Topics: Blood Diseases
|
EpiCast Report: Hemophilia - Epidemiology Forecast to 2026
Topics: Blood Diseases, Drug Discovery
|
Aplastic Anemia - Pipeline Insight, 2017
Topics: Blood Diseases, Drug Discovery
|
Chemotherapy Induced Anemia - Market Insights, Epidemiology and Market Forecast – 2025
|
Chemotherapy Induced Anemia - Epidemiology Insights to 2025
Topics: Blood Diseases
|
Von Willebrand Disease - Epidemiology Insights to 2025
Topics: Blood Diseases
|
Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2017
Topics: Blood Diseases, Research & Development, Drug Discovery
|
Iron Deficiency Anemia - Pipeline Review, H2 2017
Topics: Blood Diseases, Drug Discovery
|
Market Access Impact (EU5) [Haemophilia B]
Topics: Blood Diseases
|
Hemophilia A - Pipeline Review, H1 2017
Topics: Blood Diseases, Drug Discovery
|
France Hemophilia Treatment Drugs Market : Prospects, Trends Analysis, Market Size and Forecasts up to 2022
Topics: Blood Diseases
Regions: France
|
Ireland Hemophilia Treatment Drugs Market : Prospects, Trends Analysis, Market Size and Forecasts up to 2022
Topics: Blood Diseases
Regions: Ireland
|
United States Hemophilia Treatment Drugs Market : Prospects, Trends Analysis, Market Size and Forecasts up to 2022
Topics: Blood Diseases
Regions: United States
|
Market Access Impact (US) [Haemophilia A]
Topics: Blood Diseases
Regions: United States
|
Market Access Impact (EU5) [Haemophilia A]
Topics: Blood Diseases
|
Global Neutropenia Treatment Market Research Report 2017
Topics: Blood Diseases
Regions: Global
|
Blood Disease Drugs Companies in China
Topics: Blood Diseases, Pharmaceuticals Company Reports
Regions: China
|
2017 U.S. Patient care - Blood diseases sold through Offices of physicians-Product & Services Report
Topics: Blood Diseases, Physicians' Offices
Regions: United States
|
2017 U.S. Patient care - Blood diseases sold through Medical & surgical hospitals-Product & Services Report
Topics: Blood Diseases, Hospitals & Clinics
Regions: United States
|
Hemophilia - Market Insights, Epidemiology and Market Forecast-2023
Topics: Blood Diseases
|
Global Neutropenia Treatment Market 2017-2021
Topics: Blood Diseases, Research & Development
Regions: Global
|
India Hemophilia Treatment Drugs Market : Prospects, Trends Analysis, Market Size and Forecasts up to 2022
Topics: Blood Diseases
Regions: India
|
China Hemophilia Treatment Drugs Market : Prospects, Trends Analysis, Market Size and Forecasts up to 2022
Topics: Blood Diseases
Regions: China
|
Germany Hemophilia Treatment Drugs Market : Prospects, Trends Analysis, Market Size and Forecasts up to 2022
Topics: Blood Diseases
Regions: Germany
|
Hemophilia B - Pipeline Review, H1 2017
Topics: Blood Diseases, Drug Discovery
|
Blood Disease Drugs Markets in China
Topics: Blood Diseases, Prescription Drugs, Drug Discovery
Regions: China
|
Sickle Cell Disease - Pipeline Review, H1 2017
Topics: Blood Diseases, Drug Discovery
|
